ArticlePharmaceutics2023

A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia.

Alicia Martín Roldán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.